Abbott Laboratories grabbed attention in early June with its announcement of a partnership with Tandem Diabetes Care Inc. to develop a multianalyte sensor for people with diabetes that would measure ketones as well as glucose. Read More
The U.K. government will soon unveil its 10-year health plan to transform the National Health Service. The aim is to tackle the problems in the 76-year-old system and make it fit for the future. The aim is to tackle the problems in the 76-year-old system and make it fit for the future. Read More
With a growing number of people wearing continuous glucose monitors and an ever-shrinking number of hospital-based nurses, bringing your own device or using personal CGMs to measure glucose levels during hospitalizations seems like a no-brainer. Read More
A June 25 hearing in the U.S. House of Representatives highlighted some of the health care spending benefits of remote patient monitoring, but Medicare payment is seen as deficient – a problem that may be resolved by pending legislation. Read More
According to a new listing at the FDA device recalls and alerts webpage, Dublin-based Medtronic plc., requested customers quarantine any Bravo CF capsules, an esophageal pH monitoring system. Read More
Ophthalmology company Polyactiva Pty Ltd closed a AU$40 million (US$25 million) series C round to advance late-stage clinical trials in the U.S. of its lead candidate, PA-5108. Read More
Med-tech firms raising money in public or private financings, including: Elfie, Empo Health, Icecure Medical, Lifeward, Nephrolytics, Trisalus Life Sciences. Read More
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cardiosense, Genedx, Glucotrack, Onetwo Analyics. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alafair, Entera, Intelligent Bio, Mainz Biomed, Micropure, Raybiotech, Seastar, Spjotgard, Tivic Health, Venebio. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Femasys, GE Healthcare, Inspiremd. Read More
